✦ LIBER ✦

A Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab with or Without Bevacizumab as Frontline Therapy for Metastatic Colorectal Cancer. A Fox Chase Extramural Research Study

✍ Scribed by Efrat Dotan, Neal J. Meropol, Barbara Burtness, Crystal S. Denlinger, James Lee, David Mintzer, Fang Zhu, Karen Ruth, Holly Tuttle, Judi Sylvester, Steven J. Cohen

Book ID: 118821269
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 212 KB
Volume: 43
Category: Article
ISSN: 1941-6628
DOI: 10.1007/s12029-012-9368-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a Phase II Trial of Cetuximab

Results of a Phase II Trial of Cetuximab plus Capecitabine/Irinotecan as First-Line Therapy for Patients with Advanced and/or Metastatic Colorectal Cancer

✍ Thomas Cartwright; Paul Kuefler; Allen Cohn; William Hyman; Maury Berger; Donald 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 144 KB

A randomised phase III study on capecita

A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

✍ Tol, J.; Koopman, M.; Rodenburg, C. J.; Cats, A.; Creemers, G. J.; Schrama, J. G 📂 Article 📅 2008 🏛 Oxford University Press 🌐 English ⚖ 76 KB

3068 POSTER Capecitabine + irinotecan +

3068 POSTER Capecitabine + irinotecan + bevacizumab as first-line therapy for patients (pts) with metastatic colorectal cancer (MCRC): preliminary phase II study results

✍ S. Beslija; M. Banjin; S. Jungic; N. Obralic; G. Kecman-Malcic; I. Rakita; B. Sa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 80 KB

A phase II randomized study of cetuximab

A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma

✍ Andrew H. Ko, Hagop Youssoufian, Jayne Gurtler, Karel Dicke, Omar Kayaleh, Heinz 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 177 KB

Capecitabine in combination with oxalipl

Capecitabine in combination with oxaliplatin as first line therapy for patients (pts) with advanced or metastatic colorectal cancer (ACRC): preliminary results of an international multicenter phase II study

✍ Twelves, C.; Butts, C.; Cassidy, J.; Conroy, Th.; DeBraud, F.; Díaz-Rubio, E.; F 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Axitinib and/or bevacizumab with modifie

Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: A randomized phase 2 study

✍ Infante, Jeffrey R.; Reid, Tony R.; Cohn, Allen L.; Edenfield, William J.; Cesco 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB